Larson Financial Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.2K | Buy |
1,543
+810
| +111% | +$12.2K | ﹤0.01% | 1410 |
|
|
2025
Q1 | $9.67K | Hold |
733
| – | – | ﹤0.01% | 1639 |
|
|
2024
Q4 | $11.6K | Sell |
733
-2
| -0.3% | -$32 | ﹤0.01% | 1428 |
|
|
2024
Q3 | $11.6K | Hold |
735
| – | – | ﹤0.01% | 1414 |
|
|
2024
Q2 | $11.2K | Hold |
735
| – | – | ﹤0.01% | 1223 |
|
|
2024
Q1 | $10.8K | Hold |
735
| – | – | ﹤0.01% | 1022 |
|
|
2023
Q4 | $10.2K | Hold |
735
| – | – | ﹤0.01% | 1010 |
|
|
2023
Q3 | $9.8K | Buy |
735
+5
| +0.7% | +$67 | ﹤0.01% | 1002 |
|
|
2023
Q2 | $9.2K | Hold |
730
| – | – | ﹤0.01% | 960 |
|
|
2023
Q1 | $8.3K | Hold |
730
| – | – | ﹤0.01% | 980 |
|
|
2022
Q4 | $7.54K | Hold |
730
| – | – | ﹤0.01% | 942 |
|
|
2022
Q3 | $8K | Buy |
730
+5
| +0.7% | +$55 | ﹤0.01% | 852 |
|
|
2022
Q2 | $8K | Hold |
725
| – | – | ﹤0.01% | 786 |
|
|
2022
Q1 | $8K | Hold |
725
| – | – | ﹤0.01% | 713 |
|
|
2021
Q4 | $9K | Hold |
725
| – | – | ﹤0.01% | 710 |
|
|
2021
Q3 | $9K | Buy |
725
+5
| +0.7% | +$62 | ﹤0.01% | 616 |
|
|
2021
Q2 | $11K | Hold |
720
| – | – | ﹤0.01% | 542 |
|
|
2021
Q1 | $9K | Hold |
720
| – | – | ﹤0.01% | 570 |
|
|
2020
Q4 | $10K | Hold |
720
| – | – | ﹤0.01% | 497 |
|
|
2020
Q3 | $10K | Hold |
720
| – | – | ﹤0.01% | 436 |
|
|
2020
Q2 | $8K | Hold |
720
| – | – | ﹤0.01% | 430 |
|
|
2020
Q1 | $6K | Hold |
720
| – | – | ﹤0.01% | 355 |
|
|
2019
Q4 | $6K | Hold |
720
| – | – | ﹤0.01% | 354 |
|
|
2019
Q3 | $5K | Buy |
720
+5
| +0.7% | +$35 | ﹤0.01% | 370 |
|
|
2019
Q2 | $5K | Hold |
715
| – | – | ﹤0.01% | 317 |
|
|
2019
Q1 | $6K | Hold |
715
| – | – | ﹤0.01% | 276 |
|
|
2018
Q4 | $5K | Buy |
+715
| New | +$5K | ﹤0.01% | 278 |
|